![Carl Kraus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Kraus
Directeur Technique/Scientifique/R&D chez
i3 Research, Inc.
Fortune : 1 M $ au 30/06/2026
Profil
Carl N.
Kraus was the founder of Arrevus, Inc., founded in 2015, where the titles held included Chairman, President & Chief Executive Officer from 2017 to 2021.
The current job is Medical Director at i3 Research, Inc. Former jobs include Chief Medical Officer at Idera Pharmaceuticals, Inc., Chief Medical Officer at Resilience Government Services, Inc., Chief Medical Officer at Aceragen, Inc. from 2021 to 2023, and Chief Medical Officer at Aquestive Therapeutics, Inc. from 2023 to 2025.
Education includes undergraduate studies at Washington University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/10/2025 | 282 475 ( 0,23 % ) | 1 M $ | 30/06/2026 |
Postes actifs de Carl Kraus
| Sociétés | Poste | Début |
|---|---|---|
i3 Research, Inc.
 i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts oncology, central nervous system, and respiratory research | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Carl Kraus
| Sociétés | Poste | Fin |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 04/11/2025 |
| ACERAGEN, INC. | Directeur Technique/Scientifique/R&D | 30/04/2023 |
Arrevus, Inc.
 Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Directeur Général | 31/10/2021 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Directeur Technique/Scientifique/R&D | - |
Resilience Government Services, Inc.
 Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Operates as an integrated biopharmaceutical company | Directeur Technique/Scientifique/R&D | - |
Formation de Carl Kraus
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts oncology, central nervous system, and respiratory research | Commercial Services |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Operates as an integrated biopharmaceutical company | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
